Alternative prometteuse aux tensioactifs couramment utilisés dans les formulations biologiques.


Therapeutic proteins are inherently unstable and are sensitive to temperature change, shearing, shaking, solvents, ionic strength, purity, protein concentration, pressure and freeze/thaw-drying cycles. Of all the various degradation pathways possible, aggregation is one of the most common and a cause for great concern. Formulation is a key component that is required in order to produce a stable and efficacious biologic medicine.

Many excipients are used within biologic drug formulations, including a range of surfactants called polysorbates. As a potential functional alternative to surfactants within biologic formulations, KLEPTOSEⓇ can act as an inhibitor of protein aggregation in liquid formulations by:

  • Shielding hydrophobic interactions to block potential protein-protein interaction which causes aggregation.
  • Displacing proteins induced by air-water interface.


KLEPTOSE® BioPharma (hydroxypropyl beta cyclodextrin) represents a promising alternative to surfactants commonly used within biologic formulations. Formulations containing KLEPTOSE® BioPharma perform better than the reference formulations containing polysorbates, when subjected to stress conditions of shaking (1400 rpm) and temperature (40°C). It represents a functional alternative to surfactants within biologic formulations.

Notre site utilise des cookies pour l'utilisation des statistiques Web et pour améliorer votre expérience utilisateur. Pour plus d'informations, consultez notre politique sur les cookies et apprenez comment personnaliser le réglage des cookies.
Cliquez sur Accepter pour autoriser les cookies et accéder directement au site.